Status:
COMPLETED
Improved Language Acquisition With Levodopa
Lead Sponsor:
University Hospital Muenster
Conditions:
Healthy
Eligibility:
MALE
20-35 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether the non-daily administration of levodopa is effective in boosting semantic language acquisition in healthy subjects.
Detailed Description
Our prior work using a between-subject design shows that daily administration of d-amphetamine or the dopamine precursor levodopa over the course of five days markedly improves word learning success i...
Eligibility Criteria
Inclusion
- Healthy subjects
- 20-35 years old
- Right handedness
Exclusion
- Neurological/psychiatric/metabolic/cardiac disorders
- Asthma
- Known allergic reactions to one of the experimental drugs
- Other drugs affecting the central nervous system
- Leisure drug ingestion during the past 4 weeks (urine test)
- Smoking cessation during the past 2 weeks
- \> 6 cups of coffee or energy drinks per day
- \> 10 cigarettes per day
- \> 50 grams of alcohol per day
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00103805
Start Date
March 1 2003
End Date
August 1 2005
Last Update
May 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Neurology, University Hospital Muenster
Münster, North Rhine-Westphalia, Germany, 48129